Ascendis Health (JSE:ASC) Piotroski F-Score: 0 (As of Jun. 26, 2026)


JSE:ASC Ascendis Health Ltd JSE:ASC
11 GF Score
Price R0.92
View Full Analysis

What is Ascendis Health Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ascendis Health has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Ascendis Health's Piotroski F-Score or its related term are showing as below:

Ascendis Health  (JSE:ASC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Ascendis Health Piotroski F-Score Related Terms


Ascendis Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Ascendis Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Health Piotroski F-Score Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 5.00 3.00 5.00 5.00

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 0.00 5.00 0.00 5.00
JSE:ASC
11GF Score
Ascendis Health Ltd JSE:ASC
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Net Income was R75 Mil.
Cash Flow from Operations was R-140 Mil.
Revenue was R1,535 Mil.
Gross Profit was R605 Mil.
Average Total Assets from the begining of this year (Jun22)
to the end of this year (Jun23) was (1677.598 + 970.711) / 2 = R1324.1545 Mil.
Total Assets at the begining of this year (Jun22) was R1,678 Mil.
Long-Term Debt & Capital Lease Obligation was R19 Mil.
Total Current Assets was R748 Mil.
Total Current Liabilities was R380 Mil.
Net Income was R449 Mil.

Revenue was R1,559 Mil.
Gross Profit was R638 Mil.
Average Total Assets from the begining of last year (Jun21)
to the end of last year (Jun22) was (10634.966 + 1677.598) / 2 = R6156.282 Mil.
Total Assets at the begining of last year (Jun21) was R10,635 Mil.
Long-Term Debt & Capital Lease Obligation was R162 Mil.
Total Current Assets was R1,159 Mil.
Total Current Liabilities was R1,089 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ascendis Health's current Net Income (TTM) was 75. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ascendis Health's current Cash Flow from Operations (TTM) was -140. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun22)
=75.322/1677.598
=0.04489872

ROA (Last Year)=Net Income/Total Assets (Jun21)
=449.2/10634.966
=0.04223803

Ascendis Health's return on assets of this year was 0.04489872. Ascendis Health's return on assets of last year was 0.04223803. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Ascendis Health's current Net Income (TTM) was 75. Ascendis Health's current Cash Flow from Operations (TTM) was -140. ==> -140 <= 75 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Jun23
=19.306/1324.1545
=0.01457987

Gearing (Last Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=162.403/6156.282
=0.02638005

Ascendis Health's gearing of this year was 0.01457987. Ascendis Health's gearing of last year was 0.02638005. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun23)=Total Current Assets/Total Current Liabilities
=747.906/380.409
=1.96605759

Current Ratio (Last Year: Jun22)=Total Current Assets/Total Current Liabilities
=1158.564/1088.618
=1.06425211

Ascendis Health's current ratio of this year was 1.96605759. Ascendis Health's current ratio of last year was 1.06425211. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Ascendis Health's number of shares in issue this year was 606.241. Ascendis Health's number of shares in issue last year was 479.809. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=604.531/1535.437
=0.39371918

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=637.734/1559.458
=0.40894593

Ascendis Health's gross margin of this year was 0.39371918. Ascendis Health's gross margin of last year was 0.40894593. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun22)
=1535.437/1677.598
=0.9152592

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun21)
=1559.458/10634.966
=0.14663498

Ascendis Health's asset turnover of this year was 0.9152592. Ascendis Health's asset turnover of last year was 0.14663498. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+1+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ascendis Health has an F-score of 5 indicating the company's financial situation is typical for a stable company.


Ascendis Health Business Description

Address 1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score

Get the complete analysis for JSE:ASC

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.92
Price